HomeALXO • NASDAQ
add
ALX Oncology Holdings Inc
Previous close
$1.18
Day range
$1.01 - $1.18
Year range
$0.41 - $2.36
Market cap
56.76M USD
Avg Volume
1.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.47M | -43.47% |
Net income | -25.95M | 34.14% |
Net profit margin | — | — |
Earnings per share | -0.44 | 28.22% |
EBITDA | -23.28M | 43.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 79.31M | -49.39% |
Total assets | 95.32M | -55.59% |
Total liabilities | 30.90M | -44.11% |
Total equity | 64.42M | — |
Shares outstanding | 53.55M | — |
Price to book | 0.98 | — |
Return on assets | -54.28% | — |
Return on capital | -63.28% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.95M | 34.14% |
Cash from operations | -23.41M | 11.89% |
Cash from investing | 22.32M | 2,360.42% |
Cash from financing | -222.00K | -100.82% |
Net change in cash | -1.31M | -187.88% |
Free cash flow | -15.06M | -7.05% |
About
Founded
2015
Headquarters
Website
Employees
49
